The best ASX growth shares to buy while they're still on sale

Analysts see major upside for investors with these top stocks.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Market selloffs can feel ruthless in the moment. But for long-term investors, they also open the door to some of the best opportunities — especially when it comes to quality ASX growth shares trading at a discount.

Right now, several of the ASX's most promising companies have been dragged down by broader market weakness, despite their businesses continuing to grow.

Here are three ASX growth shares analysts think investors should buy while they're still on sale.

A smiling woman holds a Facebook like sign above her head.

Image source: Getty Images

Life360 Inc. (ASX: 360)

Life360 has quietly become one of the most exciting tech stories on the ASX. Best known for its eponymous family safety app, the company is growing fast in the U.S. and expanding internationally, with paid subscriber numbers rising rapidly.

While the recent tech selloff has pulled its share price back, this has nothing to do with its performance. Life360 continues to deliver strong top-line growth and improving unit economics. For investors chasing exposure to global SaaS with sticky customers and recurring revenue, Life360 looks like a compelling opportunity at current levels.

Goldman Sachs rates it as a buy with a $27.00 price target. This compares favourably to its current share price of $19.00.

Pro Medicus Ltd (ASX: PME)

Pro Medicus is no stranger to premium valuations — and for good reason. The health imaging software provider boasts jaw-dropping margins, long-term contracts with some of the world's top hospitals, and zero debt on its balance sheet.

Its Visage imaging platform is used by radiologists across the U.S., Europe, and beyond, and demand continues to grow as healthcare providers seek more efficient and scalable solutions.

Pro Medicus shares have pulled back massively from their highs in line with the broader tech sector, but the business itself keeps powering ahead. For those willing to take a long-term view, this could be a rare chance to buy one of the ASX's true compounders at a discount.

Bell Potter is bullish on Pro Medicus and has a buy rating and $280.00 price target. At present, its shares are changing hands for $204.18.

WiseTech Global Ltd (ASX: WTC)

Finally, WiseTech could be an ASX growth share to buy. It has copped a heavy selloff this year — down around 40% from its 52-week high — following some short-term headwinds and concerns over growth expectations caused by internal drama. But zoom out, and the long-term story remains intact.

Its CargoWise platform is used by the world's largest freight and logistics operators, with massive runway still ahead as the company expands globally and vertically across the supply chain.

The business is profitable, cash-generative, and has a huge addressable market — and while near-term sentiment has taken a hit, those with patience could be well rewarded as WiseTech continues to embed itself into the global logistics ecosystem.

Goldman Sachs currently has a buy rating and $128.00 price target on its shares. This compares to its current share price of $84.83.

Motley Fool contributor James Mickleboro has positions in Life360, Pro Medicus, and WiseTech Global. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group, Life360, and WiseTech Global. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended WiseTech Global. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

flying asx share price represented by man flying remote control drone
Growth Shares

Why are DroneShield shares suddenly rising again?

A guidance miss, then a sharp bounce. What changed?

Read more »

Person handing out $50 notes, symbolising ex-dividend date.
Growth Shares

Where I'd invest $25,000 into ASX shares in August

I outline why these shares could be top picks for investors this month and for years to come.

Read more »

A female soldier flies a drone using hand-held controls.
Growth Shares

ASX defence shares have been the trade of the decade. Is it too late to join the party?

Order books are growing. Share prices aren't.

Read more »

Group of people cheer around tablets in office
Growth Shares

3 growing ASX 300 shares I'd buy with $5,000

All three businesses have something to prove, but strong execution could make them considerably larger over time.

Read more »

Excited couple celebrating success while looking at smartphone.
Growth Shares

5 ASX shares I'd buy with $5,000 in August

I think these ASX 200 shares are now trading below fair value.

Read more »

A boy stands in front of two similar but slightly different doors, scratching his head as to which one to choose.
Growth Shares

Looking for both growth and income? This ASX share is the perfect choice

You don't always have to choose between growth and income.

Read more »

Three business people stand on platforms in the desert and look out through telescopes.
Growth Shares

2 top ASX shares to buy and hold for the next decade

These ASX shares have a lot to offer long-term investors.

Read more »

Woman using a pen on a digital stock market chart in an office.
Growth Shares

My top ASX 200 stock picks for August

I think the next decade could give these market leaders plenty of time to deepen their advantages.

Read more »